Daily Respiratory Research Analysis
Analyzed 88 papers and selected 3 impactful papers.
Summary
Three clinically impactful respiratory studies stood out: an adult diagnostic algorithm for primary ciliary dyskinesia (PCD) combining clinical criteria with nasal nitric oxide showed high accuracy; longitudinal MRI across the lifespan in PCD mapped early-onset structural and perfusion abnormalities and their progression; and an open-label randomized trial found RAM cannula was not non-inferior to nasal mask for CPAP in preterm neonates with respiratory distress syndrome. Together, these inform diagnosis, monitoring, and frontline neonatal respiratory support.
Research Themes
- Adult diagnostic accuracy and screening algorithms in primary ciliary dyskinesia
- Radiation-free imaging endpoints and disease monitoring across the lifespan
- Interface selection for neonatal noninvasive respiratory support in low-resource settings
Selected Articles
1. Accuracy of clinical phenotype for diagnosing adults with primary ciliary dyskinesia.
In 156 adults referred for possible PCD, ≥2 of 4 key clinical criteria yielded 95% sensitivity and 88% specificity for definite PCD. Adding infertility/subfertility to the criteria (≥2 of 5) increased sensitivity to 100% with 84% specificity. A nasal nitric oxide threshold <77 nL/min achieved 88% sensitivity and 98% specificity.
Impact: Provides a pragmatic, high-accuracy adult diagnostic algorithm that integrates phenotype with nNO, addressing a key gap in adult PCD diagnostics.
Clinical Implications: Adults with suspected PCD can be triaged using ≥2 of 5 features (including infertility/subfertility) plus nNO screening to prioritize confirmatory testing, potentially reducing invasive diagnostics and delays.
Key Findings
- Among 156 adults, 26% had definite PCD, 4% probable, and 70% were unlikely.
- ≥2 of 4 key criteria achieved 95% sensitivity and 88% specificity.
- Adding infertility/subfertility (≥2 of 5 features) raised sensitivity to 100% with 84% specificity.
- Nasal nitric oxide <77 nL/min showed 88% sensitivity and 98% specificity.
Methodological Strengths
- Standardized collection of key clinical features and nNO in all referred adults over 2013–2024.
- Use of genetic testing and/or TEM confirmation triggered by predefined criteria and nNO thresholds.
Limitations
- Retrospective, single-center referral cohort with potential selection/referral bias.
- External validation across diverse adult populations is needed.
Future Directions: Prospective multicenter validation and cost-effectiveness analyses of nNO-augmented clinical algorithms; evaluate integration into stepwise diagnostic pathways.
BACKGROUND: Primary ciliary dyskinesia (PCD) is a heterogenous disease that is difficult to diagnose. Investigations for PCD are recommended with an appropriate phenotype of four "key PCD clinical criteria": (1) year-round wet cough from before 6 months old, (2) year-round nasal congestion from before 6 months old, (3) neonatal respiratory distress at term birth, and/or (4) an organ laterality defect. Accuracy of these symptoms was validated in children but not robustly explored in adults. RESEARCH QUESTION: Among adults referre
2. Longitudinal Changes in Lung Morphology and Perfusion Detected by Magnetic Resonance Imaging in Patients with Primary Ciliary Dyskinesia From Infancy Through Adulthood.
MRI showed that bronchiectasis/wall thickening, mucus plugging, consolidation, and perfusion defects are already common in infancy and increase by adulthood. The MRI global score rose significantly in adulthood and correlated with FEV1 and Bronchiectasis Severity Index, supporting MRI as a monitoring and trial endpoint.
Impact: Defines radiation-free imaging biomarkers that capture early-onset and progressive PCD lung disease, providing objective measures aligned with lung function and severity.
Clinical Implications: Supports early MRI-based surveillance in PCD and adoption of standardized MRI scoring as trial endpoints; combining morphology and perfusion enhances sensitivity to disease burden.
Key Findings
- At infancy, bronchiectasis/wall thickening (100%), mucus plugging (80%), consolidation (60%), and perfusion abnormalities (50%) were prevalent.
- By adulthood, mucus plugging (97%), consolidation (80%), and perfusion abnormalities (97%) increased.
- MRI global score increased from 14.5±4.5 (infancy) to 26.7±7.2 (adulthood) and correlated with FEV1% predicted (r=-0.44 to -0.71) and BSI (r=0.44–0.49).
Methodological Strengths
- Comprehensive longitudinal imaging with 189 MRIs across 75 PCD patients from infancy to adulthood.
- Blinded dual-reader scoring of morphology and perfusion with correlation to spirometry and BSI.
Limitations
- Observational design with potential selection bias; timing of serial scans and sedation considerations not detailed.
- Single-center or limited-center generalizability cannot be excluded.
Future Directions: Standardize PCD MRI protocols and scoring; multicenter validation of MRI as a surrogate endpoint; integrate perfusion metrics into risk stratification.
BACKGROUND: Magnetic resonance imaging (MRI) revealed a high prevalence of lung abnormalities in children with primary ciliary dyskinesia (PCD). However, longitudinal imaging data on the onset and progression are lacking. RESEARCH QUESTION: When do abnormalities in lung morphology and perfusion in patients with PCD first emerge, and how do they longitudinally progress from infancy through adulthood as assessed by MRI? STUDY DESIGN: and Methods: 189 MRI examinations (mean examinations per patient 2.4±1.7, range
3. Ram cannula vs nasal mask interface for providing CPAP in preterm neonates (< 34 weeks) with respiratory distress syndrome in a low- and middle-income country: an open-label, non-inferiority randomized controlled trial.
In 210 preterm neonates with RDS, mechanical ventilation within 72 hours occurred in 21% with RAM cannula versus 12% with nasal mask (risk difference 8.57%, 95% CI −1.44 to 18.59), failing to meet the pre-specified 15% non-inferiority margin. Nasal injury, duration of CPAP, mortality, and common morbidities were comparable.
Impact: Provides randomized evidence from a resource-limited setting that challenges the assumed equivalence of RAM cannula to nasal mask for nCPAP in preterm RDS.
Clinical Implications: When aiming to reduce intubation in preterm RDS, prefer nasal mask over RAM cannula for nCPAP where feasible; monitor for nasal injury similarly in both interfaces.
Key Findings
- Mechanical ventilation within 72 h: 21% (RAM cannula) vs 12% (nasal mask); non-inferiority not established (margin 15%).
- Other outcomes (nasal injury incidence/severity, CPAP duration, mortality, common morbidities) were comparable.
- Baseline characteristics were similar between groups; 105 infants per arm.
Methodological Strengths
- Randomized, non-inferiority design with pre-specified margin and trial registration.
- Pragmatic comparison of commonly used interfaces in a low- and middle-income country setting.
Limitations
- Open-label design may introduce performance bias.
- Single-center context and precision limitations around the non-inferiority boundary may affect generalizability.
Future Directions: Larger multicenter trials with standardized CPAP protocols and stratification by gestational age; evaluate alternative interfaces and nurse-driven care bundles.
UNLABELLED: The present open-label, non-inferiority randomized controlled trial aimed to determine the efficacy and safety of RAM cannula as compared to nasal mask on the need for mechanical ventilation within 72 h of initiation of nCPAP. Preterm neonates (< 34 weeks) with Silverman-Anderson Score ≥ 3/10 were allocated to either RAM cannula or nasal mask for providing nCPAP. Two hundred and ten neonates were enrolled in the study, 105 each in the RAM cannula group and nasal mask group, respectively. Baseline characte